Evidence map›Paper›PMID 32960186›Full record

Observational studyBMJ (Clinical research ed.)2020

Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study.

Olivia V Swann, Karl A Holden, Lance Turtle, Louisa Pollock, Cameron J Fairfield, Thomas M Drake, Sohan Seth, Conor Egan, Hayley E Hardwick, Sophie Halpin and 19 more

Open access · hybridAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in BMJ (Clinical research ed.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 327 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
327citing papers in PubMed, 7 pooled it
123.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

327 citing papers in PubMed, 7 syntheses or guidelines pooled it, 690 citations in OpenAlex.

  1. Pooled it
  2. Mucosal immune response in biology, disease prevention and treatment.Signal transduction and targeted therapy · 2025
    Pooled it
  3. Risk Factors for Pediatric Critical COVID-19: A Systematic Review and Meta-Analysis.Journal of the Pediatric Infectious Diseases Society · 2024
    Pooled it
  4. Pooled it
  5. Guideline
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Article
  13. Article
  14. Article
  15. Article
  16. Observational
  17. Article
  18. Article
  19. Article
  20. Article

267 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 9 institutions in 1 country.

Olivia V SwannDepartment of Child Life and Health, University of Edinburgh, Edinburgh, UK.
Karl A HoldenWomen's and Children's Health, Institute of Translational Medicine, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, UK.
Lance TurtleInstitute of Infection, Veterinary and Ecological Sciences, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, UK.
Louisa PollockPaediatric Infectious Diseases, Royal Hospital for Children, Glasgow, UK.
Cameron J FairfieldCentre for Medical Informatics, Usher Institute, University of Edinburgh, Edinburgh, UK.
Thomas M DrakeCentre for Medical Informatics, Usher Institute, University of Edinburgh, Edinburgh, UK.
Sohan SethInstitute for Adaptive and Neural Computation, School of Informatics, University of Edinburgh, UK.
Conor EganInstitute for Adaptive and Neural Computation, School of Informatics, University of Edinburgh, UK.
Hayley E HardwickInstitute of Infection, Veterinary and Ecological Sciences, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, UK.
Sophie HalpinLiverpool Clinical Trials Centre, University of Liverpool, Liverpool, UK.
Michelle GirvanLiverpool Clinical Trials Centre, University of Liverpool, Liverpool, UK.
Chloe DonohueLiverpool Clinical Trials Centre, University of Liverpool, Liverpool, UK.
Mark PritchardCentre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Latifa B PatelRespiratory Medicine, Alder Hey Children's Hospital, Liverpool, UK.
Shamez LadhaniImmunisation and Countermeasures Division, Public Health England, Colindale, UK.
Louise SigfridISARIC Global Support Centre, Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Ian P SinhaWomen's and Children's Health, Institute of Translational Medicine, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, UK.
Piero L OlliaroISARIC Global Support Centre, Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Jonathan S Nguyen-Van-TamDivision of Epidemiology and Public Health, University of Nottingham School of Medicine, Nottingham, UK.
Peter W HorbyISARIC Global Support Centre, Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Laura MersonISARIC Global Support Centre, Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Gail CarsonISARIC Global Support Centre, Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Jake DunningNational Infection Service, Public Health England, [A: Where?].
Peter J M OpenshawNational Heart and Lung Institute, Imperial College London, London, UK.
J Kenneth BaillieRoslin Institute, University of Edinburgh, Edinburgh, UK.
Ewen M HarrisonCentre for Medical Informatics, Usher Institute, University of Edinburgh, Edinburgh, UK.
Annemarie B DochertyCentre for Medical Informatics, Usher Institute, University of Edinburgh, Edinburgh, UK.
Malcolm G SempleRespiratory Medicine, Alder Hey Children's NHS Foundation Trust, Liverpool L12 2AP, UK m.g.semple@liverpool.ac.uk.ORCID 0000-0001-9700-0418
ISARIC4C Investigators
University of Liverpool · GBUniversity of Oxford · GBUniversity of Edinburgh · GBPublic Health England · GBRoyal Hospital for Children · GBDepartment of Health and Social Care · GBEdinburgh Royal Infirmary · GBImperial College London · GBRoslin Institute · GB

Funding

Department of Health IS-HPU-1112-10117Medical Research Council MC_PC_19025Medical Research Council MC_PC_19059Medical Research Council MR/S032304/1Medical Research Council MR/V033441/1
6 · The paper itself

Abstract

objectiveTo characterise the clinical features of children and young people admitted to hospital with laboratory confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in the UK and explore factors associated with admission to critical care, mortality, and development of multisystem inflammatory syndrome in children and adolescents temporarily related to coronavirus disease 2019 (covid-19) (MIS-C).

designProspective observational cohort study with rapid data gathering and near real time analysis.

setting260 hospitals in England, Wales, and Scotland between 17 January and 3 July 2020, with a minimum follow-up time of two weeks (to 17 July 2020).

participants651 children and young people aged less than 19 years admitted to 138 hospitals and enrolled into the International Severe Acute Respiratory and emergency Infections Consortium (ISARIC) WHO Clinical Characterisation Protocol UK study with laboratory confirmed SARS-CoV-2.

main outcome measuresAdmission to critical care (high dependency or intensive care), in-hospital mortality, or meeting the WHO preliminary case definition for MIS-C.

resultsMedian age was 4.6 (interquartile range 0.3-13.7) years, 35% (225/651) were under 12 months old, and 56% (367/650) were male. 57% (330/576) were white, 12% (67/576) South Asian, and 10% (56/576) black. 42% (276/651) had at least one recorded comorbidity. A systemic mucocutaneous-enteric cluster of symptoms was identified, which encompassed the symptoms for the WHO MIS-C criteria. 18% (116/632) of children were admitted to critical care. On multivariable analysis, this was associated with age under 1 month (odds ratio 3.21, 95% confidence interval 1.36 to 7.66; P=0.008), age 10-14 years (3.23, 1.55 to 6.99; P=0.002), and black ethnicity (2.82, 1.41 to 5.57; P=0.003). Six (1%) of 627 patients died in hospital, all of whom had profound comorbidity. 11% (52/456) met the WHO MIS-C criteria, with the first patient developing symptoms in mid-March. Children meeting MIS-C criteria were older (median age 10.7 (8.3-14.1)

conclusionsChildren and young people have less severe acute covid-19 than adults. A systemic mucocutaneous-enteric symptom cluster was also identified in acute cases that shares features with MIS-C. This study provides additional evidence for refining the WHO MIS-C preliminary case definition. Children meeting the MIS-C criteria have different demographic and clinical features depending on whether they have acute SARS-CoV-2 infection (polymerase chain reaction positive) or are post-acute (antibody positive). STUDY REGISTRATION: ISRCTN66726260.

Indexed as

BetacoronavirusAdolescentAge FactorsChildChild, PreschoolCohort StudiesCoronavirus InfectionsCOVID-19Critical CareFemaleHospitalizationHospital MortalityHumansInfantInfant, NewbornMale

Identifiers

PMID32960186
PMCPMC7488201
OpenAlexW3080979105

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.